Aethlon (AEMD) 2026 Earnings: What Investors Should Watch
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
This article outlines scenarios where target date funds may be preferable to index funds in a 401(k), focusing on simplicity and risk management.
26,105 articlesSmall-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Through the first half of 2026, mega funds over $1B captured about 72% of all VC capital raised, while first-time man...
President Trump’s Mount Rushmore appearance on Independence Day stirred political headlines and market caution. Early...
A high-stakes pivot: the team behind ethereum's institutional privacy push launches EthSystems, a for-profit venture ...
The CEO of a $1B AI unicorn pushes back on doom-laden talk about job loss, arguing that funding cycles and strategic ...
Trump’s tariff threat makes markets pivot, accelerating a rotation from U.S. stocks to international equities. The Va...
XRP's leverage and open interest have tumbled, but ETF funds and Ripple's expansion keep money in the ecosystem. Trad...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
As of May 2026, the U.S. tech economy hinges on institutional design that turns ideas into markets. This piece explai...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
Jim Cramer won’t touch POET as retail investors drive a volatile rally. This report tracks the catalysts, the bets, a...
Japan is advancing legislation to regulate crypto like stocks, aiming to lower taxes and unlock regulated crypto ETFs...